Labels
Posted by

David Livermore fights NDM-1, the 'super' superbug

David Livermore and NDM-1
There is a new story at MSNBC.com highlighting David Livermore, NDM-1, and the myriad of reasons for the expansion of MDR-bacteria and hospital infections: little investment in antibiotic discovery and infection prevention.  I like this quote from the article in regards to infection prevention: "If it is done properly, it can ease the demand for drugs in the first place."  Dr. Livermore is the Director of the Antibiotic Resistance Monitoring & Reference Laboratory (ARMRL) at the HPA Centre for Infections in London. The story is surprisingly well-written, includes the usual human-interest angle and quite long but worth a read.

h/t Mark Vander Weg
Email Post
Labels:

Comments

  1. Maryn McKennaApril 1, 2011 at 8:43 AM

    You guys might want to talk a look at a piece I did for Scientific American this month, on carbapenem resistance. Unfortunately only the preview is available on the web (frown), but it is 4k words long and pretty detailed.
    http://www.scientificamerican.com/article.cfm?id=the-enemy-within

    ReplyDelete

Post a Comment

Thanks for submitting your comment to the Controversies blog. To reduce spam, all comments will be reviewed by the blog moderator prior to publishing. However, all legitimate comments will be published, whether they agree with or oppose the content of the post.

Most Read Posts (Last 30 Days)